Skip to main content

Advertisement

Log in

The rare IRF2BP2-RARA fusion in acute promyelocytic leukemia

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Mazharuddin S, Chattopadhyay A, Levy MY, Redner RL (2018) IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid. Leuk Lymphoma 59(9):2246–2249. https://doi.org/10.1080/10428194.2017.1421761

  2. Soliman H, Khalil F, Antonia S (2014) PD-L1 expression is increased in a subset of basal type breast cancer cells. PLoS ONE 9(2):e88557. https://doi.org/10.1371/journal.pone.0088557

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Blotta S, Tassone P, Prabhala RH et al (2009) Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance. Blood 114(15):3276–3284. https://doi.org/10.1182/blood-2009-04-219436

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Nyquist KB, Panagopoulos I, Thorsen J et al (2012) Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma. PLoS ONE 7(11):e49705. https://doi.org/10.1371/journal.pone.0049705

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Alotaibi AS, Abdulrazzaq M, Patel KP, Ravandi F, Konoplev S, Bueso-Ramos C, Yin CC, Muzzafar T, Tang G, Futreal A, Jain N, Konopleva MY, Pemmaraju N (2020) Acute promyelocytic leukemia (APL) with an IRF2BP2-RARA fusion transcript: an aggressive APL variant. Leuk Lymphoma 61(12):3018–3020

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhihua Zhang.

Ethics declarations

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 88 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, X., Zhang, R. & Zhang, Z. The rare IRF2BP2-RARA fusion in acute promyelocytic leukemia. Ann Hematol 101, 2101–2102 (2022). https://doi.org/10.1007/s00277-022-04874-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-022-04874-z

Navigation